• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cefotaxime and ceftriaxone use evaluation in pediatrics. Considerations of cost effectiveness.

作者信息

Lee C K, Glenn D J

机构信息

Department of Pharmacy Services, Johns Hopkins Hospital, Baltimore, MD 21287, USA.

出版信息

Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):231-3. doi: 10.1016/0732-8893(95)00081-k.

DOI:10.1016/0732-8893(95)00081-k
PMID:7587045
Abstract

In 1993, there was a change from ceftriaxone to cefotaxime in the inpatient pediatric division of the Johns Hopkins Hospital. The annual cost savings resulting from this change were estimated. The educational efforts of the pediatric division pharmacists resulted in an increase in appropriate drug selection from 55% to 93%. The estimated annual cost saving was $18,618.

摘要

相似文献

1
Cefotaxime and ceftriaxone use evaluation in pediatrics. Considerations of cost effectiveness.
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):231-3. doi: 10.1016/0732-8893(95)00081-k.
2
Therapeutic exchange of cefotaxime for ceftriaxone: evaluation, implementation, and subsequent cost savings at a 300-bed community hospital.
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):235-7. doi: 10.1016/0732-8893(95)00099-v.
3
[Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].头孢曲松与头孢噻肟治疗复杂性泌尿系统感染的成本效益比较研究
Actas Urol Esp. 1997 Jul-Aug;21(7):668-74.
4
[Cost-effectiveness analysis of ceftriaxone and cefotaxime in the treatment of community-acquired pneumonia].
Rev Invest Clin. 2000 Jul-Aug;52(4):418-26.
5
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
S Afr Med J. 1998 Sep;88(9):1046, 1048; author reply 1050-1.
6
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.头孢噻肟。对其用于治疗感染的药物经济学综述。
Pharmacoeconomics. 1998 Jan;13(1 Pt 1):91-106. doi: 10.2165/00019053-199813010-00009.
7
A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery.
Arch Surg. 1996 Jul;131(7):744-8. doi: 10.1001/archsurg.1996.01430190066016.
8
Evaluating the cost-effectiveness of treatment with third-generation cephalosporins.评估第三代头孢菌素治疗的成本效益。
Diagn Microbiol Infect Dis. 1992 Jan;15(1):99-105. doi: 10.1016/0732-8893(92)90063-y.
9
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.头孢曲松治疗成年住院患者社区获得性肺炎的成本效益。一项基于荟萃分析的药物经济学研究。
S Afr Med J. 1998 Mar;88(3):251-5.
10
Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis.肌内注射头孢曲松与口服头孢克肟治疗青少年淋菌性宫颈炎的成本效益决策分析。
Ann Emerg Med. 1996 Mar;27(3):299-304. doi: 10.1016/s0196-0644(96)70263-9.

引用本文的文献

1
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.头孢噻肟。对其抗菌活性和药代动力学特性的重新评估,以及对其每日两次给药治疗轻至中度感染时的治疗效果的综述。
Drugs. 1997 Mar;53(3):483-510. doi: 10.2165/00003495-199753030-00009.